Phil Taylor

Showing 9 posts of 9 posts found.

mabthera image

EMA backs MabThera despite contamination issue

May 29, 2012
Manufacturing and Production EMA, MabThera, Phil Taylor, Roche, manufacturing

The European Medicines Agency has completed a safety review of Roche’s MabThera convened after bacterial contamination was discovered in bioreactors …

Merck image

Merck extends biocatalysis collaboration with Codexis

May 29, 2012
Manufacturing and Production Codexis, Merck, Phil Taylor, Victrelis, manufacturing

Biocatalyst specialist Codexis has signed a three-year extension of its catalyst and process development collaboration with Merck to develop enzymes …

Lonza image

Gene therapy specialist and Lonza forge production pact

May 22, 2012
Manufacturing and Production Avalanche, Lonza, Phil Taylor

Avalanche Biotechnologies, a US company developing gene therapies for ocular diseases, has signed a manufacturing collaboration with Lonza of Switzerland.  …

Mitsubishi Tanabe exits API business

May 22, 2012
Manufacturing and Production API, Mitsubishi, Phil Taylor, Tanabe

Mitsubishi Tanabe Pharma has said it will withdraw from the fine chemical business, including active pharmaceutical ingredient (API) supply, and …

Genentech taken to task over Avastin production

May 15, 2012
Manufacturing and Production Genentech, Phil Taylor, avastin, manufacturing

FDA inspections of a manufacturing facility for Roche/Genentech’s cancer drug Avastin (bevacizumab) uncovered a number of deficiencies which could increase …

BASF buys Equateq to tap into growing health ingredient business

May 11, 2012
Manufacturing and Production BASF, Equateq, Phil Taylor, omega-3

BASF has said it intends to buy Equateq, a UK-based specialist in lipid ingredients that represent a ‘global growing market’, …

Outsourcing on the up, but contract manufacturing still under pressure

May 11, 2012
Manufacturing and Production CMO, Jim Millar, PharmaSource, Phil Taylor, outsourcing

The pharmaceutical contract services sector experienced something for a recovery in 2011 after a lean couple of years, although the …

Pharma manufacturing news in brief

November 23, 2010
Manufacturing and Production Alpah Biologics, Alpha Biologics, Kemwell, Lonza, Phil Taylor, Roche

Facility updates from Roche, Alpha Biologics, Kemwell and Reinnervate, new contract services from Lonza and Patheon, plus a milestone in …

Latest content